Company intelligence / Profile preview
Apotex Inc.
- Ownership
- Private
- Employees
- ~8000
- Development stage
- Commercial
Overview
Apotex is the largest Canadian-based pharmaceutical company specializing in generic medications with over 300 products selling in over 115 countries. The company has a significant presence in the United States and is a health partner of choice for the Americas.
- Therapeutic areas
- CardiovascularPsychiatryOphthalmologyEndocrinologyHematologyOncologyNeurologyInfectious Diseases
- Modalities
- Small molecule drugsBiosimilarsColony-stimulating factorsMonoclonal antibodiesSynthetic peptidesRecombinant polypeptides
- Industry
- Biotech
Drug pipeline
12 assets11 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Apotex Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Apotex Inc..